Schedule 13D ownership disclosure

TURNING POINT THERAPEUTICS I

Security class unavailable · CUSIP: 90041T108

Event date: 2020-10-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,273,618
Percent of class
4.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001387131-20-009681
Form type
SC 13D/A
Filer
GSK plc
CIK
CIK 1131399
Filed
Nov 06, 2020
Reporting period
Oct 29, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub